Skip to main content
Equibles

LSL · LSL Pharma Group Inc. · Financials

Use LSL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LSL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
0.31 CAD +0.005 (+1.64%) At close · Nov 6 Intraday price with Plus
Rebalance outlook locked
Market Cap
39.29M CAD
Shares
126.73M
Volume · Nov 6 10K Avg daily vol (3M) 36.34K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
28.74M +62%
FY2025 Revenue FY2024–FY2025
Net Income
-2.82M -185%
FY2025 Net Income FY2024–FY2025
Gross Margin
17.75% -12.4pp
FY2025 Gross Margin FY2024–FY2025
Operating Margin
-7.41% -12pp
FY2025 Operating Margin FY2024–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024
CAD 28.74M 17.75M
CAD 5.1M 5.35M
CAD -2.13M 824K
CAD -2.89M 3.37M
CAD -65K 50K
CAD -2.82M 3.32M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.